BeOne Medicines AG
ONC | NASDAQ
$387.25
+$9.47 (+2.51%)
At close: Nov 5, 2026, 4:00 PM ET
$385.00
-$2.25 (-0.58%)
After-hours:
Nov 5, 2026, 6:33 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.13B | 5.74B | 5.34B | 4.97B | 4.56B | 4.18B | 3.81B | 3.32B | 3.1B | 2.76B | 2.46B | 2.2B | 1.81B | 1.56B | 1.42B | 1.25B | 1.07B | 877.04M | 1.18B | 1.06B | 947.04M | 862.69M |
Cost of Revenue | 680.68M | 670.75M | 668.54M | 686.68M | 660.63M | 634.16M | 594.09M | 539.36M | 465.21M | 423.07M | 379.92M | 347.61M | 327.84M | 303.03M | 286.48M | 261.5M | 232.37M | 197.46M | 164.91M | 137.44M | 111.15M | 89.19M |
Gross Profit | 5.45B | 5.07B | 4.67B | 4.29B | 3.9B | 3.54B | 3.22B | 2.78B | 2.63B | 2.34B | 2.08B | 1.86B | 1.48B | 1.25B | 1.13B | 988.31M | 836.25M | 679.58M | 1.01B | 924.97M | 835.9M | 773.49M |
Operating Income | 923.1M | 685.94M | 447.14M | 182.68M | -100.7M | -295.75M | -568.2M | -872.57M | -886.27M | -1.1B | -1.21B | -1.29B | -1.6B | -1.72B | -1.79B | -1.89B | -1.92B | -1.95B | -1.44B | -1.35B | -1.33B | -1.21B |
Interest Income | 116.72M | 92.32M | 77.51M | 27.18M | 34.8M | 44.53M | 47.84M | 56.3M | 72.31M | 74.15M | 74.01M | 75.95M | 62.06M | 58.43M | 52.48M | 34.26M | 21.5M | 10.07M | n/a | n/a | n/a | 1.11M |
Pretax Income | 868.08M | 655.17M | 416.85M | 182.26M | -63.21M | -268.68M | -533M | -798.42M | -470.78M | -732.32M | -825.84M | -906.03M | -1.69B | -1.88B | -1.96B | -2.12B | -2B | -1.92B | -1.44B | -1.33B | -1.34B | -1.19B |
Net Income | 655.71M | 513.02M | 286.93M | 68.55M | -177.64M | -392.37M | -644.79M | -860.46M | -523.7M | -784.43M | -881.71M | -959.49M | -1.73B | -1.92B | -2B | -2.14B | -2.02B | -1.94B | -1.44B | -1.32B | -1.31B | -1.17B |
Selling & General & Admin | 2.23B | 2.18B | 2.08B | 2.03B | 1.96B | 1.86B | 1.83B | 1.74B | 1.65B | 1.6B | 1.51B | 1.42B | 1.38B | 1.31B | 1.28B | 1.26B | 1.2B | 1.1B | 990.12M | 891.83M | 783.44M | 675.2M |
Research & Development | 2.29B | 2.21B | 2.15B | 2.07B | 2.04B | 1.97B | 1.95B | 1.91B | 1.86B | 1.83B | 1.78B | 1.73B | 1.7B | 1.66B | 1.64B | 1.62B | 1.55B | 1.53B | 1.46B | 1.38B | 1.38B | 1.31B |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.84M | 1.84M | 2.03M | 2.21M | 563K | 750K | 750K | 751K | 750K | 751K | 750K | 750K | 751K | 750K | 751K |
Operating Expenses | 4.53B | 4.38B | 4.23B | 4.1B | 4B | 3.84B | 3.78B | 3.65B | 3.52B | 3.44B | 3.29B | 3.15B | 3.08B | 2.97B | 2.92B | 2.88B | 2.75B | 2.63B | 2.45B | 2.28B | 2.17B | 1.99B |
Interest Expense | 72.63M | 32.89M | 7M | 7M | 7M | 7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.48M | 6.71M | 11.58M | 15.76M | 16.46M | 14.85M | 9.98M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.21B | 5.05B | 4.9B | 4.79B | 4.66B | 4.47B | 4.38B | 4.19B | 3.98B | 3.86B | 3.67B | 3.5B | 3.41B | 3.27B | 3.21B | 3.14B | 2.99B | 2.83B | 2.62B | 2.41B | 2.28B | 2.08B |
Income Tax Expense | 212.37M | 142.15M | 129.92M | 113.71M | 114.44M | 123.69M | 111.79M | 62.04M | 52.92M | 52.1M | 55.87M | 53.46M | 45.85M | 40.32M | 42.78M | 27.26M | 25.98M | 17.6M | -975K | -9.15M | -22.61M | -23.86M |
Shares Outstanding (Basic) | 111.58M | 110.96M | 109.06M | 110.22M | 108.57M | 106.93M | 106.26M | 104.7M | 104.7M | 104.27M | 104.08M | 104.67M | 104.63M | 104.17M | 103.76M | 103.48M | 102.8M | 102.46M | 95.03M | 92.77M | 91.85M | 91.46M |
Shares Outstanding (Diluted) | 115.8M | 115.77M | 113.45M | 114.52M | 112.85M | 111.17M | 106.26M | 104.7M | 104.7M | 104.27M | 104.08M | 106.95M | 104.63M | 104.17M | 103.76M | 103.48M | 102.8M | 102.46M | 95.03M | 92.77M | 91.85M | 96.73M |
EPS (Basic) | 76.05 | 49.92 | 23.27 | 14.17 | -1.69 | -3.77 | -6.24 | -30.29 | -27.04 | -29.51 | -30.42 | -35.49 | -42.90 | -44.85 | -45.76 | -21.32 | -20.41 | -20.02 | -14.95 | -14.04 | -14.43 | -13.52 |
EPS (Diluted) | 72.28 | 46.41 | 21.19 | 13 | -1.69 | -3.77 | -6.24 | -30.29 | -27.17 | -29.64 | -30.55 | -35.62 | -42.90 | -44.85 | -45.76 | -21.32 | -20.41 | -20.02 | -15.08 | -14.17 | -14.56 | -13.65 |
EBITDA | 1.16B | 901.83M | 629.29M | 345.21M | 133.75M | -83.22M | -362.06M | -653.91M | -376.05M | -639.37M | -738.16M | -824.16M | -1.61B | -1.81B | -1.89B | -2.05B | -1.93B | -1.86B | -1.37B | -1.28B | -1.29B | -1.18B |
EBIT | 1B | 751.8M | 487.6M | 189.26M | -56.2M | -261.67M | -533M | -798.42M | -470.78M | -732.32M | -825.84M | -906.03M | -1.69B | -1.88B | -1.96B | -2.11B | -1.99B | -1.91B | -1.42B | -1.32B | -1.33B | -1.21B |
Depreciation & Amortization | 154.93M | 150.03M | 141.69M | 155.95M | 189.96M | 178.45M | 170.94M | 144.51M | 94.73M | 92.96M | 87.68M | 81.87M | 76.56M | 69.69M | 66.28M | 61.38M | 57.36M | 53.43M | 46.46M | 41.16M | 37.33M | 33.67M |
Add to Watchlist
Select watchlists to add or remove ONC